文献速递冠心病

冠状动脉钙化评分在基层稳定胸痛评估中的整群随机试验

Coronary calcium scoring in the evaluation of stable chest pain in general practice: a cluster-randomised trial.
PubMed 文献 · Heart · 2026-08-17

CONCRETE 研究将 101 家荷兰全科诊所整群随机分为 CACS 组或标准诊疗组,评估全科医生使用 CACS 对稳定胸痛患者的诊断效率与心血管风险管理的影响。结果显示,CACS 组患者转诊心内科比例相对降低 47.1%,但诊所层面 CVRM 登记增加无显著差异。

要点

  • 全科医生使用 CACS 可使稳定胸痛患者心内科转诊率从 80.3% 降至 42.5%。
  • CACS 组 CVRM 入组率 36.3%,高于标准诊疗组的 17.0%。
  • CACS 越高,转诊心内科和诊断 OCAD 的概率越高,CACS≥400 时 OCAD 诊断率达 21.2%。

核心结论

  • 在疑似 OCAD 概率(极)低的稳定胸痛患者中,CACS 是有效的诊断工具,可减少不必要的心内科转诊并加强个体化预防。
  • CACS 对诊所层面的 CVRM 登记增加无显著影响(CACS 组 +0.3% vs SOC 组 +0.2%,p=0.77)。

研究设计与样本

  • CONCRETE 为实用、非盲的实现性研究,将 101 家荷兰全科诊所整群随机分为 CACS 组或标准诊疗组。
  • 纳入年龄≥40 岁(男)或≥45 岁(女)、无已知 CAD、可能的 cardiac 或 non-cardiac 胸痛患者。
  • 主要结局为诊所层面 CVRM 登记 2 年比例增加;患者层面次要结局包括心内科转诊率、OCAD 诊断和 CVRM 入组。
  • 符合方案分析纳入 583 例患者(57.5% 女性,平均年龄 60.6±9.1 岁),CACS 组 466 例,SOC 组 117 例,2019 年 1 月至 2023 年 10 月招募。

主要发现

  • CACS 组心内科转诊相对减少 47.1%(42.5% vs 80.3%;模型差异 31.3%,95%CI 14.8% 至 47.8%)。
  • OCAD 检出率两组无显著差异(CACS 4.9% vs SOC 7.7%,p=0.14)。
  • CACS 越高,转诊心内科概率越高(CACS 0 为 8.4%,CACS≥400 为 94.2%,差异 +85.7%,95%CI 79.4% 至 91.9%)。
  • CACS 越高,OCAD 诊断概率越高(CACS 0 为 0%,CACS≥400 为 21.2%,OR 9.08,95%CI 4.20 至 19.67)。
  • CACS 组 CVRM 入组率高于 SOC 组(36.3% vs 17.0%,p<0.01)。

临床怎么用

  • 对疑似 OCAD 概率(极)低的稳定胸痛患者,可考虑以 CACS 作为一线检查以减少不必要的心内科转诊。
  • CACS 结果可辅助判断转诊心内科的必要性:CACS 0 时转诊概率低,CACS≥400 时转诊概率高。
  • CACS 有助于识别需要加强心血管风险管理的患者,提高 CVRM 入组率。

局限性

  • 研究为实用、非盲的实现性研究,存在实施偏倚可能。
  • 符合方案分析中 CACS 组与 SOC 组样本量差异较大(466 例 vs 117 例)。
  • 主要结局在诊所层面未显示显著差异,患者层面获益需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: General practitioners (GPs) have limited tools for chest pain patients to identify (non-)obstructive coronary artery disease (OCAD). This trial evaluates whether GP access to the coronary artery calcium score (CACS) improves diagnostic efficiency and cardiovascular risk management (CVRM). METHODS: COroNary Calcium scoring as fiRst-linE Test to dEtect and exclude coronary artery disease in GP patients with stable chest pain (CONCRETE) is a pragmatic, non-blinded implementation study that cluster-randomised 101 Dutch GP offices into CACS or standard of care (SOC). Patients aged ≥40 (men) or ≥45 (women) years, without known CAD, with possible cardiac or non-cardiac chest pain were included. The primary outcome was the proportional 2-year increase in CVRM registrations at GP office level. Patient-level secondary outcomes included cardiologist referral rate, OCAD diagnosis and CVRM enrolment. RESULTS: At GP office level, no significant difference in CVRM registration increase was seen for CACS versus SOC (46 CACS practices: +0.3%, 45 SOC practices: +0.2%, p=0.77). Per protocol analysis for patient-level outcomes included 583 patients (57.5% women, mean age 60.6±9.1 years) (CACS arm: 466; SOC arm: 117), recruited between January 2019 and October 2023. The CACS arm showed 47.1% relative reduction in cardiologist referrals compared with SOC (42.5% vs 80.3%; modelled difference 31.3% (95% CI 14.8% to 47.8%)). OCAD detection rates were not significantly different (CACS: 4.9, SOC: 7.7%, p=0.14). Patients with higher CACS had a higher probability of cardiologist referral (from 8.4% for CACS 0 to 94.2% for CACS ≥400, difference +85.7% (95% CI 79.4% to 91.9%)) and of OCAD diagnosis (0% for CACS 0 to 21.2% for CACS ≥400, OR 9.08 (95% CI 4.20 to 19.67)). Compared with SOC, more CACS patients were enrolled in CVRM (36.3% vs 17.0%, p<0.01). CONCLUSIONS: In this pragmatic, primary-care implementation and proof-of-concept trial, CACS was an effective diagnostic test for stable chest pain patients with (very) low likelihood of OCAD. CACS reduced unnecessary cardiology referrals and enhanced individual preventive care, without demonstrable practice-level impact on CVRM registrations. REGISTRATION: The CONCRETE study is registered under CCMO Register NL66821.042.18 and closed for enrolment.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Koopman, Severijn, Reijnders, et al. Coronary calcium scoring in the evaluation of stable chest pain in general practice: a cluster-randomised trial. Heart. 2026. PMID: 42604789. doi:10.1136/heartjnl-2025-327687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。